Versant Vantage I, L.P. - Insider Non-Derivative Transactions at Black Diamond Therapeutics, Inc. (BDTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 28, 2024, Versant Vantage I, L.P.'s relationship to Black Diamond Therapeutics, Inc. (BDTX) is TenPercentOwner, and currently has 3,726,341 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BDTX insiders.
Data Source: SEC.
Versant Vantage I, L.P. - Insider Non-Derivative Transactions at BDTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 29, 2024 | Sell -- (Common Stock) | 221600 | 6.32 | 3726341 |